ARS Pharmaceuticals Inc (SPRY)
8.66
-0.28
(-3.13%)
USD |
NASDAQ |
Jun 14, 16:00
8.64
-0.02
(-0.23%)
After-Hours: 20:00
ARS Pharmaceuticals Total Liabilities (Quarterly): 3.715M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.715M |
| December 31, 2023 | 2.428M |
| September 30, 2023 | 11.27M |
| June 30, 2023 | 10.20M |
| Date | Value |
|---|---|
| March 31, 2023 | 10.04M |
| December 31, 2022 | 8.549M |
| June 30, 2022 | 90.08M |
| December 31, 2021 | 92.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.428M
Minimum
Dec 2023
92.72M
Maximum
Dec 2021
28.62M
Average
10.12M
Median
Total Liabilities (Quarterly) Benchmarks
| KalVista Pharmaceuticals Inc | 25.38M |
| Phathom Pharmaceuticals Inc | 505.00M |
| Vera Therapeutics Inc | 65.81M |
| Nuvalent Inc | 33.43M |
| CEL-SCI Corp | 15.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 227.58M |
| Shareholders Equity (Quarterly) | 223.87M |